These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29109268)

  • 1. Syntenin mediates SRC function in exosomal cell-to-cell communication.
    Imjeti NS; Menck K; Egea-Jimenez AL; Lecointre C; Lembo F; Bouguenina H; Badache A; Ghossoub R; David G; Roche S; Zimmermann P
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12495-12500. PubMed ID: 29109268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2.
    Ghossoub R; Lembo F; Rubio A; Gaillard CB; Bouchet J; Vitale N; Slavík J; Machala M; Zimmermann P
    Nat Commun; 2014 Mar; 5():3477. PubMed ID: 24637612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase activates the syndecan-syntenin-ALIX exosome pathway.
    Roucourt B; Meeussen S; Bao J; Zimmermann P; David G
    Cell Res; 2015 Apr; 25(4):412-28. PubMed ID: 25732677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntenin and syndecan in the biogenesis of exosomes.
    Friand V; David G; Zimmermann P
    Biol Cell; 2015 Oct; 107(10):331-41. PubMed ID: 26032692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.
    Baietti MF; Zhang Z; Mortier E; Melchior A; Degeest G; Geeraerts A; Ivarsson Y; Depoortere F; Coomans C; Vermeiren E; Zimmermann P; David G
    Nat Cell Biol; 2012 Jun; 14(7):677-85. PubMed ID: 22660413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntenin-knock out reduces exosome turnover and viral transduction.
    Kashyap R; Balzano M; Lechat B; Lambaerts K; Egea-Jimenez AL; Lembo F; Fares J; Meeussen S; Kügler S; Roebroek A; David G; Zimmermann P
    Sci Rep; 2021 Feb; 11(1):4083. PubMed ID: 33602969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loading with syndecan and EpCAM cargo.
    Leblanc R; Kashyap R; Barral K; Egea-Jimenez AL; Kovalskyy D; Feracci M; Garcia M; Derviaux C; Betzi S; Ghossoub R; Platonov M; Roche P; Morelli X; Hoffer L; Zimmermann P
    J Extracell Vesicles; 2020 Dec; 10(2):e12039. PubMed ID: 33343836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
    Garcia M; Hoffer L; Leblanc R; Benmansour F; Feracci M; Derviaux C; Egea-Jimenez AL; Roche P; Zimmermann P; Morelli X; Barral K
    Eur J Med Chem; 2021 Nov; 223():113601. PubMed ID: 34153575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6.
    Zimmermann P; Zhang Z; Degeest G; Mortier E; Leenaerts I; Coomans C; Schulz J; N'Kuli F; Courtoy PJ; David G
    Dev Cell; 2005 Sep; 9(3):377-88. PubMed ID: 16139226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression.
    Lee KM; Seo EC; Lee JH; Kim HJ; Hwangbo C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase Involvement in Exosome Formation.
    David G; Zimmermann P
    Adv Exp Med Biol; 2020; 1221():285-307. PubMed ID: 32274714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntenin: Key player in cancer exosome biogenesis and uptake?
    Fares J; Kashyap R; Zimmermann P
    Cell Adh Migr; 2017 Mar; 11(2):124-126. PubMed ID: 27589080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation-regulated phase separation of syndecan-4 and syntenin promotes the biogenesis of exosomes.
    Zhao T; Yang X; Duan G; Chen J; He K; Chen YX; Luo SZ
    Cell Prolif; 2024 Oct; 57(10):e13645. PubMed ID: 38601993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntenin, a syndecan adaptor and an Arf6 phosphatidylinositol 4,5-bisphosphate effector, is essential for epiboly and gastrulation cell movements in zebrafish.
    Lambaerts K; Van Dyck S; Mortier E; Ivarsson Y; Degeest G; Luyten A; Vermeiren E; Peers B; David G; Zimmermann P
    J Cell Sci; 2012 Mar; 125(Pt 5):1129-40. PubMed ID: 22399807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraspanin-6 negatively regulates exosome production.
    Ghossoub R; Chéry M; Audebert S; Leblanc R; Egea-Jimenez AL; Lembo F; Mammar S; Le Dez F; Camoin L; Borg JP; Rubinstein E; David G; Zimmermann P
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5913-5922. PubMed ID: 32108028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling.
    Luyten A; Mortier E; Van Campenhout C; Taelman V; Degeest G; Wuytens G; Lambaerts K; David G; Bellefroid EJ; Zimmermann P
    Mol Biol Cell; 2008 Apr; 19(4):1594-604. PubMed ID: 18256285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
    Hwangbo C; Kim J; Lee JJ; Lee JH
    Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
    Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1.
    Lee H; Kim Y; Choi Y; Choi S; Hong E; Oh ES
    Biochem Biophys Res Commun; 2011 May; 409(1):148-53. PubMed ID: 21569759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
    Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
    Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.